30th ISCB International Conference

ISCBC-2025

Current Trends in Chemical, Biological and Pharmaceutical Sciences: Impact on Health and Environment

International Advisory Board ISCBC-2025

International Advisory Board ISCBC-2025

  • Prof Jyoti Chattopadhyaya, Chair of Chemical Biology, Uppsala University, Uppsala, Sweden
  • Prof Mike Threadgill, University of Bath, Claverton Down, Bath , UK
  • Prof Dr. Stefan Brase, Karlsruhe Institute of Technology, Karlsruhe,Germany
  • Prof Kazuaki Matsumura, Japan Advanced Institute Science and Technology, Japan
  • Prof Kwang-Soo Kim, Professor and Director, Molecular Neurobiology Laboratory, McLean Hospital/Harvard Medical School, Boston, USA
  • Prof Athina Geronikaki, University,of Thessaloniki, Thessaloniki, Greece
  • Prof Colin J Suckling, Research Professor of Chemistry, Department of Pure & Applied Chemistry, University of Strathclyde, Glasgow, Scotland
  • Prof A. Ganesan, School of Pharmacy, University of East Anglia,United Kindgom
  • Prof Om Prakash, Kansas State University, Manhattan, USA
  • Prof Binghe Wang, Georgia State University,Atlanta, Georgia, USA
  • Dr Ute Schepers, KIT, Institut for Toxikologie und Genetik, Germany
  • Prof Dr. Erik Van der Eycken, Katholieke Universiteit Leuven, Belgium
  • Prof Alvarez Mercedes, University of Barcelona, Spain
  • Dr Mukund S. Chorghade, President & Chief Scientific Officer, THINQ Pharma, USA
  • Prof Mahesh K. Lakshman, The City College and The City University of New York, USA
  • Prof Rachna Sadana, University of Houston-Downtown, Houston, USA
  • Prof Karol Grela, Polish Academy of Sciences, Warsaw, Poland
  • Prof Christophe LEN, Universit de Technologie de Compigne, France
  • Prof Rui Moreira, University of Lisbon,Portugal
  • Prof Sun CHOI, College of Pharmacy & Graduate School of Pharmaceutical Sciences, EwhaWomans University, Seoul, Korea
  • Prof Girolamo Cirrincione, Emeritus Professor of Medicinal Chemistry, University of Palermo, Via Archirafi, 32 - 90123 Palermo, Italy
  • Prof To Ngai, Dept. of Chemistry, The Chinese University of, Hong Kong
  • Prof Anoja Attanayake, Department of Biochemistry, Faculty of Medicine, University of Ruhuna, Sri Lanka
  • Prof Barbara Zajc, Department of Chemistry and Biochemistry, The City College of New York, USA
  • Prof Dipak P. Ramji, Cardiff School of Biosciences, Cardiff University, Cardiff, UK
  • Dr Edmond Differding, Managing Director, Differding Consulting, Luxembourg
  • Dr Harsha Rajapakse, Department of Chemistry and Environmental Science, Medgar Evers College, The City University of New York, Brooklyn, New York, USA
  • Prof Marco L. Lolli, Assistant Professor in Medicinal Chemistry, Dept. Science and Drug Technology - University of Turin (UniTO), Italy
  • Prof Michele Vittadello, Professor of Chemistry and Nanoscience, Medgar Evers College of the City University of New York, Energy Nanotechnology and Materials Chemistry Team, 1638 Bedford Avenue, Brooklyn, NY, USA
  • Prof Nigel G. J. Richards, Department of Chemistry, Cardiff University, Cardiff, UK
  • Prof Ramaiah Muthyala, Centre for orphan drug development, University of Minneapolis, MN, USA
  • Prof Premysl Mladenka, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
  • Prof Katsuhiko Ariga, World Premier International (WPI) Research Center for Materials Nanoarchitectonics National Institute for Materials Science 1-1 Namiki, Tsukuba, Ibaraki, Japan
  • Dr Anna Kajetanowicz, Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, Warsaw, Poland
  • Prof Krishna Kumar, Department of Chemistry, Tufts University, Medford, MA, USA